Insider trade

McKesson Corporation (MCK): CEO sold ~$5.38M

Brian S. Tyler, CEO at McKesson Corporation, sold ~$5.38M of McKesson Corporation shares.

~$5.38M
Approx. value · 8,961 sh @ $600.66
70K
Holds after · shares reported
Traded
Feb 14, 2025
Filed
Feb 18, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 2, 2025InsiderOfficer sold ~$332K of MCK shares in the open market
  2. Jan 15, 2025Congress · 1 personMembers of Congress: 2 purchases
  3. Jan 24, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
  4. Feb 12, 2025InsiderOfficer sold ~$115K of MCK shares in the open market
  5. Feb 14, 2025 · this disclosureInsiderCEO sold ~$5.38M of MCK shares in the open market

What came next

  1. Feb 21, 2025InsiderCEO sold ~$5.36M of MCK shares in the open market
  2. Feb 25, 2025InsiderOfficer sold ~$189K of MCK shares in the open market
  3. Feb 28, 2025InsiderCEO sold ~$5.59M of MCK shares in the open market
  4. Mar 4, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  5. Mar 6, 2025InsiderCEO sold ~$5.68M of MCK shares in the open market
  6. Apr 9, 2025CongressDisclosed partial sale of MCK — reported range $1,001 - $15,000
  7. Apr 24, 2025FDARecall: SEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CONTROL SET.
  8. Apr 24, 2025FDARecall: ABBOTT POINT OF CARE TEST CREA I-STAT (25/BX) ABBTPT CARTRIDGE.
  9. Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC ANTI-B BIOCLONE 10ML3X10ML.
  10. Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC VITROS BUN (60/CR 5CR/PK) ORCLNL REAGENT.
  11. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCH AUSAB ANTI-HBS (100/EA) REAGENT.
  12. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCHITECT PROGESTERONE (100TESTS) REAGENT.
  13. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCHITECT FREE T4ABBDIA CALIBRATOR.
  14. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARC ANTI-TPO ASSAY 100TST B REAGENT.
  15. Apr 24, 2025FDARecall: ABBOTT RAPID DX N AMERICA LLC, TEST CHOLESTEC LDXLIPID PROFILE (10/BX 50BX/CS) CASSETTES.
  16. Apr 24, 2025FDARecall: HEMOCUE INC GLUC AQUEOUS 1HI/LO HEMCUE CONTROL KIT.
  17. Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC VITROS CALCIUM (L-SEQUESTER) (300/PK) REAGENT.
  18. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARC CARBON DIOXIDE6X5ML B CALIBRATOR.
  19. Apr 24, 2025FDARecall: BD MICROBIOLOGY FLUID THIOGLYCOLLATE MED TUBE 1004321196 (100/CT) MEDIA.
  20. Apr 25, 2025FDARecall: Infuvite Adult, multiple vitamins injection, Baxter, Five of Vial 1 (5 mL) and Five of Vial 2 (5mL), Rx Only, Sterile, Manufactured for: Sandoz Inc., Princeton…
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for McKesson Corporation

For McKesson Corporation, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCK page.

Other recent filings by Brian S. Tyler, Chief Executive Officer

The full history of Brian S. Tyler, Chief Executive Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which McKesson Corporation (MCK) insider traded, and how much?

Brian S. Tyler, CEO at McKesson Corporation, sold ~$5.38M of McKesson Corporation shares. 8,961 shares at $600.66.

When did it happen, and when was it made public?

Traded: Feb 14, 2025. Filed: Feb 18, 2025. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about McKesson Corporation recently?

For McKesson Corporation, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the MCK page.

Does this mean MCK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at McKesson Corporation

Everything OQRO holds on this company is on its MCK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data